These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of Streptococcus mutans glucosyltransferase activity by antiserum to a subsequence peptide. Dertzbaugh MT, Macrina FL. Infect Immun; 1990 Jun; 58(6):1509-13. PubMed ID: 2140339 [Abstract] [Full Text] [Related]
5. Antigenicity of a synthetic peptide from glucosyltransferases of Streptococcus mutans in humans. Chia JS, Lin SW, Yang CS, Chen JY. Infect Immun; 1997 Mar; 65(3):1126-30. PubMed ID: 9038329 [Abstract] [Full Text] [Related]
6. Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase. Smith DJ, Taubman MA, King WF, Eida S, Powell JR, Eastcott J. Infect Immun; 1994 Dec; 62(12):5470-6. PubMed ID: 7960128 [Abstract] [Full Text] [Related]
7. Immunization of rats with synthetic peptide constructs from the glucan-binding or catalytic region of mutans streptococcal glucosyltransferase protects against dental caries. Taubman MA, Holmberg CJ, Smith DJ. Infect Immun; 1995 Aug; 63(8):3088-93. PubMed ID: 7622235 [Abstract] [Full Text] [Related]
8. Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines. Smith DJ, King WF, Barnes LA, Trantolo D, Wise DL, Taubman MA. Infect Immun; 2001 Aug; 69(8):4767-73. PubMed ID: 11447149 [Abstract] [Full Text] [Related]
9. Functional and immunogenic characterization of two cloned regions of Streptococcus mutans glucosyltransferase I. Jespersgaard C, Hajishengallis G, Greenway TE, Smith DJ, Russell MW, Michalek SM. Infect Immun; 1999 Feb; 67(2):810-6. PubMed ID: 9916095 [Abstract] [Full Text] [Related]
10. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli. Bckström M, Holmgren J, Schödel F, Lebens M. Gene; 1995 Nov 20; 165(2):163-71. PubMed ID: 8522171 [Abstract] [Full Text] [Related]
11. Antigenicity and immunogenicity of a synthetic peptide derived from a glucan-binding domain of mutans streptococcal glucosyltransferase. Smith DJ, Taubman MA, Holmberg CF, Eastcott J, King WF, Ali-Salaam P. Infect Immun; 1993 Jul 20; 61(7):2899-905. PubMed ID: 8514393 [Abstract] [Full Text] [Related]
12. Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity. Smith DJ, Lam A, Barnes LA, King WF, Peacock Z, Wise DL, Trantolo DJ, Taubman MA. Oral Microbiol Immunol; 2003 Aug 20; 18(4):240-8. PubMed ID: 12823800 [Abstract] [Full Text] [Related]
13. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin. Katz J, Harmon CC, Buckner GP, Richardson GJ, Russell MW, Michalek SM. Infect Immun; 1993 May 20; 61(5):1964-71. PubMed ID: 8478086 [Abstract] [Full Text] [Related]
14. Immunogenicity and prediction of epitopic region of antigen Ag I/II and glucosyltransferase from Streptococcus mutans. Cao XX, Fan J, Chen J, Li YH, Fan MW. J Huazhong Univ Sci Technolog Med Sci; 2016 Jun 20; 36(3):416-421. PubMed ID: 27376814 [Abstract] [Full Text] [Related]
15. Effects of antibodies against cell surface protein antigen PAc-glucosyltransferase fusion proteins on glucan synthesis and cell adhesion of Streptococcus mutans. Yu H, Nakano Y, Yamashita Y, Oho T, Koga T. Infect Immun; 1997 Jun 20; 65(6):2292-8. PubMed ID: 9169766 [Abstract] [Full Text] [Related]
16. Molecular genetic analysis of the catalytic site of Streptococcus mutans glucosyltransferases. Kato C, Nakano Y, Lis M, Kuramitsu HK. Biochem Biophys Res Commun; 1992 Dec 15; 189(2):1184-8. PubMed ID: 1472027 [Abstract] [Full Text] [Related]
17. Analysis of the Streptococcus downei gtfS gene, which specifies a glucosyltransferase that synthesizes soluble glucans. Gilmore KS, Russell RR, Ferretti JJ. Infect Immun; 1990 Aug 15; 58(8):2452-8. PubMed ID: 2142479 [Abstract] [Full Text] [Related]
18. Intranasal immunization against dental caries with a Streptococcus mutans-enriched fimbrial preparation. Fontana M, Dunipace AJ, Stookey GK, Gregory RL. Clin Diagn Lab Immunol; 1999 May 15; 6(3):405-9. PubMed ID: 10225844 [Abstract] [Full Text] [Related]
19. A feasible enzyme-linked immunosorbent assay system using monoclonal and polyclonal antibodies against glucosyltransferase-B from Streptococcus mutans. Shinozaki-Kuwahara N, Hashizume-Takizawa T, Hirasawa M, Takada K. Hybridoma (Larchmt); 2012 Jun 15; 31(3):176-9. PubMed ID: 22741581 [Abstract] [Full Text] [Related]
20. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection. Zhang P, Jespersgaard C, Lamberty-Mallory L, Katz J, Huang Y, Hajishengallis G, Michalek SM. Infect Immun; 2002 Dec 15; 70(12):6779-87. PubMed ID: 12438353 [Abstract] [Full Text] [Related] Page: [Next] [New Search]